BioXcel Therapeutics, Inc. (BTAI) Balance Sheet Annual - Discounting Cash Flows
BTAI
BioXcel Therapeutics, Inc.
BTAI (NASDAQ)
Period Ending: 2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
Report Filing: 2025-03-28 2024-03-22 2023-03-16 2022-03-11 2021-03-12 2020-03-09 2019-03-12 2017-12-31 2016-12-31
Total Current Assets 37.39 72.14 202.9 236.8 217.1 34.11 43.17 0.89 0.002
Cash and Short Term Investments 29.85 65.22 193.7 233 213.1 32.43 42.56 0.887 0
Cash & Equivalents 29.85 65.22 193.7 233 213.1 32.43 42.56 0.887 0
Short Term Investments 0 0 0 0 0 0 0 0 0
Receivables 0.131 0.071 0.248 0 0 0 0.115 0 0
Inventory 0.679 1.99 1.99 0 0 0 0 0 0
Other Current Assets 6.73 4.86 6.91 3.84 3.95 1.68 0.491 0.003 0.002
Total Assets 38.34 73.7 205.9 239.4 219.9 36.39 43.55 1.35 0.007
Total Non-Current Assets 0.944 1.56 2.98 2.63 2.87 2.29 0.378 0.465 0.005
Property, Plant and Equipment 0.857 1.47 2.06 2.54 2.78 2.23 0.327 0.004 0.005
Goodwill and Intangible Assets 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0 0
Deferred Tax Assets 0 0 0 0 0 0 0 0 0
Other Long Term Assets 0.087 0.087 0.925 0.086 0.087 0.051 0.051 0.461 0
Total Current Liabilities 22.23 27.27 32.9 16.67 11.84 8.47 4.66 2.34 0.331
Accounts Payable 15.99 13.65 10.23 4.68 3.98 4.95 1.6 0.444 0.279
Notes Payable/Short Term Debt 0.374 0.346 0.319 0.293 0.237 0 0 0.371 0
Tax Payables 0.091 0.116 0.082 0.302 0.697 0 0 0 0
Deferred Revenue 0 0 0 0 0 -0.164 0 0 0
Other Current Liabilities 5.78 13.15 22.27 11.39 6.93 3.68 3.06 1.52 0.052
Total Liabilities 131.4 130.2 129.1 17.77 13.24 9.5 4.66 2.34 0.331
Total Non-Current Liabilities 109.2 102.9 96.18 1.1 1.4 1.03 0 0 0
Total Long Term Debt 102.6 101 93.84 1.1 1.4 1.03 0 0 0
Deferred Tax Liabilities Non-Current 0 0 0 0 0 0 0 0 0
Deferred Revenue Non-Current 0 0 0 0 0 0 0 0 0
Capital Lease Obligations 0.439 0.786 1.1 1.4 1.64 1.03 0 0 0
Other Long Term Liabilities 6.19 1.12 1.24 -1.4 -1.64 -1.03 0 0 0
Total Equity -93.1 -56.51 76.78 221.7 206.7 26.89 38.89 -0.982 -0.324
Non-Controlling Interest 0 0 0 0 0 0 0 0 0
Total Stockholders' Equity -93.1 -56.51 76.78 221.7 206.7 26.89 38.89 -0.982 -0.324
Retained Earnings -650.2 -590.6 -411.5 -245.8 -138.9 -56.69 -23.72 -4.45 0
Accumulated Other Earnings 0 0 0 0 0 0 -0.018 -0.001 0
Common Stock 0.049 0.03 0.028 0.028 0.024 0.018 0.016 0.01 0
Preferred Stock 0 0 0 0 0 0 0 0 0
Additional Paid in Capital 557 534.1 488.3 467.4 345.5 83.56 62.59 3.46 -0.324
Total Liabilities & Total Equity 38.34 73.7 205.9 239.4 219.9 36.39 43.55 1.35 0.007
Total Liabilities & Shareholders' Equity 38.34 73.7 205.9 239.4 219.9 36.39 43.55 1.35 0.007
Total Investments 0 0 0 0 0 0 0 0 0
Total Debt 102.9 101.4 94.16 1.4 1.64 1.03 0 0.371 0
Net Debt 73.09 36.16 -99.57 -231.6 -211.5 -31.4 -42.56 -0.516 0
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program